Most Awaited Q3 Sale is back. Upto 30% discount on every report.

Diabetic Foot Ulcers Market Size, Share, Industry, Forecast and Outlook (2023-2030)

Published: 2023 September 14
SKU : PH20
180 pages
Report Summary
Table of Contents
List of Tables/Figures

Global Diabetic Foot Ulcers Market is segmented Product Type (Wound Care Dressing, Biologics, Others), Ulcer Type (Neuropathic Ulcers, Neuro-Ischemic Ulcers), By End User (Hospitals, Clinics, Ambulatory Surgical Center, Homecare Setting), By Region (North America, Europe, South America, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030.


Diabetic Foot Ulcers Market Overview

The Global Diabetic Foot Ulcers Market reached US$ 5,812.7 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 9,300.6 million by 2030. The diabetic foot ulcers market is expected to exhibit a CAGR of 6.2% during the forecast period (2023-2030). A diabetic foot ulcer is an open sore or wound that occurs in roughly 15.1% of diabetic individuals and is most typically found on the bottom of the foot.

Six percent of persons who acquire a foot ulcer will be hospitalized owing to infection or another ulcer-related condition. Diabetes is the largest cause of nontraumatic lower limb amputations in the United States, and 14.3 to 24.2 % of diabetic individuals with foot ulcers suffer an amputation.


Diabetic Foot Ulcers Market Scope 





Size Available for Years


Forecast Period


Data Availability

Value (US$) 

Segments Covered

By Product Type, Ulcer Type, End User  

Regions Covered

North America, Europe, Asia-Pacific, South America and Middle East & Africa

Fastest Growing Region


Largest Region

North America

Report Insights Covered

Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights.


To know more insights Download Sample


Diabetic Foot Ulcers Market Dynamics

Increase in the Prevalence Of Diabetic Foot Ulcer 

Diabetes mellitus affects 8.8% of persons in India between the ages of 20 and 79. The diabetic foot has become one of the most prevalent and significant consequences of diabetes mellitus, resulting in hospitalization and incapacity on a regular basis. In a study, diabetic foot ulcers were discovered in a population of newly diagnosed type II diabetes mellitus patients in India, with 46.1% having neuropathic, 19.7% having ischemic, and 34.2% having neuro-ischemic foot ulcers.

Technological Advancements In Treatment Options

Various mobile phone applications are presently utilized globally to improve the quality of human existence in various fields of everyday activities. Diabetic foot ulcer monitoring and care smartphone apps are being developed. For instance, using AI and cloud-based technology, Cassidy created the first smartphone app capable of reliable DFU detection. 

This system was evaluated in a 6-month clinical trial at two NHS hospital locations in the UK (Lancashire Teaching Hospitals and Salford Royal Hospital) and is now being improved in terms of functionality and accuracy. To develop a more clinically relevant solution, further app features such as automated categorization of DFU wound pathology and automated delineation of wound/peri-wound zones are being examined.

These new technical improvements are likely to change remote wound care by allowing patients to self-monitor their DFUs and call physicians if they see any concerns or disease worsening. This would also improve flexibility in the operation of foot clinics by assessing and triaging the most relevant DFUs to be seen in clinics via remote patient monitoring.

High Cost for Treatment Of Diabetic Foot Ulcers

In India, diabetic foot ulcer treatment prices can range from Rs. 30,000 to Rs. 1,50,000. This substantial cost disparity is partly attributable to the different therapies conducted based on the severity of the ailment. Small uninfected ulcers, for example, require only cleaning and treatment, whereas large open infected wounds may necessitate limb amputation.


Diabetic Foot Ulcers Market Segment Analysis

The Neuroischemic Segment Is Expected To Dominate The Market In The Forecast Period.

Besed on the type of ulcer, diabetic foot ulcers are classified into two types: neuropathic and neuroischemic. The neuroischemic type is likely to dominate the market due to its high prevalence. The neuroischemic segment is expected to increase faster than the other segment types. According to research published in the Journal of Diabetes, neuroischemic ulcers account for around 50 of all cases. The neuroischemic segment holds about 53.2% of the total diabetic foot ulcers market in the forecast period owing to the above mentioned factors.

 Source: DataM Intelligence Analysis (2023)


Diabetic Foot Ulcers Market  Geographical Penetration

North America is the Highest Dominating Region During The Forecast Period.

The North America region holds the largest share of the global diabetic foot ulcers market accounting for around 37.7% in the forecast period. This is due to a rise in R&D facilities, which has led to improvements in treatment facilities, attracting patients. Furthermore, the expense of treatment is rather high there. Because of its large senior population, Europe is the next significant market. The Asia-Pacific region has the fastest-growing market due to an increase in the geriatric population and an increase in sickness.

Source: DataM Intelligence Analysis (2023)


Diabetic Foot Ulcers Market Players

The major global players include ConvaTec Inc, Acelity LP Inc, 3M Healthcare, Organogenesis Inc, Coloplast Corp Smith & Nephew Plc, B Braun Melsungen AG Medline Industries Inc, Medtronic, Molnlycke Healthcare AB and others.


COVID-19 Impact on Diabetic Foot Ulcers Market 

In a study in Latin America, Peru has been the most badly hit by COVID-19 infections, and observational research examined how the pandemic has affected emergency visits to the Peruvian National Trauma Referral Centre in Lima. In the first month of a lockdown, they recorded an 80% drop in the number of serious patients seen in the emergency room. 

Despite this general decrease in admissions, those with diabetic foot ulcers attended in proportion to the total number of admissions. Indeed, during the lockdown, diabetic foot condition jumped to the third most common reason for surgical admission, from eleventh in the previous months. One possible explanation for this observation is a decrease in non-COVID-19-related healthcare provision.


Key Developments

  • In October 2022, Healthium MedTech announced the launch of Theruptor Novo, a new wound dressing portfolio for the care of chronic wounds such as diabetic foot ulcers and leg ulcers. Theruptor Novo, according to the MedTech business, improves Healthium's existing range of patented solutions in the advanced wound dressing area.
  • In March 2023, Pune’s My lab partnered with UK firm to develop diabetic foot ulcer detection kitMy lab Discovery Solutions, and DNA Nudge, a pioneer in consumer genetics testing and medical diagnostics based in the United Kingdom, established strategic cooperation to create next-generation molecular diagnostic solutions for diabetic foot ulcer diagnosis and other major health issues. The diabetic foot ulcer detection kit is one of the world's first point-of-decision molecular technology solutions, allowing doctors to plan suitable antimicrobial medication regimens by offering early identification of the spectrum of microbial flora in the ulcer.

Why Purchase the Report?

  • To visualize the global diabetic foot ulcers market segmentation based on the product type, ulcer type, end user and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development. 
  • Excel data sheet with numerous data points of global diabetic foot ulcers market level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global diabetic foot ulcers market report would provide approximately 92 tables, 108 figures and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

For more Pharmaceutical reports, Please Click Here

Buy this report
Single User
Multiple User
Enterprise User
Proceed to Buy
Request new version
What is the Projected CAGR value of the Diabetic Foot Ulcers Market during the Forecast Period?
The Diabetic Foot Ulcers market is expected to grow at a CAGR of 6.2% during the forecast period.
Which region holds the largest market share in the global diabetic foot ulcers market?
North America region holds the largest market share in the global diabetic foot ulcers market.
Who are the leading end users for the diabetic foot ulcers market?
leading end users for the diabetic foot ulcers market are Hospitals, Clinics, Ambulatory Surgical Centers, Homecare Setting
Who are the Key players contributing to the market's growth?
The Key Players are Orpyx Medical Technologies Inc, Coloplast Corp, B. Braun Melsungen AG, 3M, Cardinal Health., ConvaTec Group Plc, Mölnlycke Health Care AB., Huizhou Foryou Medical Devices Co., Ltd., Wuhan Huawei Technology Co., Ltd., Changzhou Recoo Healthcare Co., Ltd.
Related Reports

Basal Insulin (Long-Acting Insulin) Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 September 27
Starting from



Oral Anti Diabetes Drugs Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 August 09
Starting from



Diabetes Therapeutics Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 June 27
Starting from



Type 2 Diabetes Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 April 18
Starting from



Diabetic Neuropathy Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 September 22
Starting from



Insulin Resistance Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2022 December 29
Starting from